from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0685/tuf

LFCtreatmentdescriptionclass of inhibitor

-0.398

Amikacinug/mL Amikacintranslation

-0.040

Cap5-10ug/mL Capreomycintranslation

-0.994

Rox10-50 ug/mL Roxithromycintranslation

1.024

SM2-5 ug/mL Streptomycintranslation

-0.363

Tet5-10 ug/mL Tetracyclinetranslation

-1.157

Rif0.2-5ug/mL Rifampicintranscription

-0.652

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.188

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.072

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.116

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.219

Clofazimine10-13 ug/mL Clofaziminerespiration

0.330

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.960

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.846

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.016

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.126

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.041

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.418

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.985

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.070

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.221

KCN5-20 ug/mL Potassium cyaniderespiration

-0.640

NaN30.2-2 mM Sodium aziderespiration

1.300

Nigericin50 uM Nigericinrespiration

-0.936

TRC10-150 ug/mL Triclosanrespiration

-1.039

TRZ10-25 ug/mL Thioridazinerespiration

-0.059

Valinomycin0.5-10 uM Valinomycinrespiration

0.707

ZnSO42 mM ZnSO4respiration

0.030

menadione6-10 ug/mL Menadionerespiration

0.354

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.913

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.528

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.943

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.735

NRP_1Non-replicating persistence stage 1dosRassociated

1.332

Amp0.2mg/mL AmpicillincellWall

0.701

Cephalexin20-100 ug/mL CephalexincellWall

0.971

Cerulenin0.32-5 ug/mL CerulenincellWall

1.173

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.612

EMB10-20 ug/mL EthambutolcellWall

0.655

Eta12-40 ug/mL EthionamidecellWall

0.536

INH0.2-0.4 ug/mL IsoniazidcellWall

0.798

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.541

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.805

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.359

BZA0.12 mg/mL BenzamidearomaticAmides

-0.159

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.368

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.796

H2O24 mM hydrogen peroxideDNAdamaging

0.645

Levo10 ug/mL LevofloxacinDNAdamaging

0.845

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.401

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.186

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.727

UVUV-irradiationDNAdamaging

-1.023

ARP41-4 ug/mL Antitubercular compound ARP4?

0.308

Antimycin12.5-50 ug/mL Antimycin A?

0.783

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.489

PA_110-50 ug/mL Antitubercular compound PA-1?

0.613

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.170

PA8240.2-2 ug/mL PA-824?

-0.846

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.186

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.872

Verapamil50 uM Verapamil?

0.849

mercaptoethanol2 mM 2-Mercaptoethanol?

0.897

methoxatin10-20 ug/mL Methoxatin?